| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2021 |
Koşaloğlu-Yalçın Z, Blazeska N, Carter H, Nielsen M, Cohen E, Kufe D, Conejo-Garcia J, Robbins P, Schoenberger SP, Peters B, Sette A. The Cancer Epitope Database and Analysis Resource: A Blueprint for the Establishment of a New Bioinformatics Resource for Use by the Cancer Immunology Community. Frontiers in Immunology. 12: 735609. PMID 34504503 DOI: 10.3389/fimmu.2021.735609 |
0.01 |
|
| 2021 |
Wang Z, Fan X, Shen Y, Pagadala MS, Signer R, Cygan KJ, Fairbrother WG, Carter H, Chung WK, Huang KL. Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes. Genome Medicine. 13: 147. PMID 34503567 DOI: 10.1186/s13073-021-00964-1 |
0.01 |
|
| 2021 |
Zhang T, Joubert P, Ansari-Pour N, Zhao W, Hoang PH, Lokanga R, Moye AL, Rosenbaum J, Gonzalez-Perez A, Martínez-Jiménez F, Castro A, Muscarella LA, Hofman P, Consonni D, Pesatori AC, ... ... Carter H, et al. Genomic and evolutionary classification of lung cancer in never smokers. Nature Genetics. 53: 1348-1359. PMID 34493867 DOI: 10.1038/s41588-021-00920-0 |
0.01 |
|
| 2021 |
Castro A, Zanetti M, Carter H. Neoantigen Controversies. Annual Review of Biomedical Data Science. 4: 227-253. PMID 34465181 DOI: 10.1146/annurev-biodatasci-092820-112713 |
0.01 |
|
| 2021 |
Ozturk K, Carter H. Predicting functional consequences of mutations using molecular interaction network features. Human Genetics. PMID 34432150 DOI: 10.1007/s00439-021-02329-5 |
0.01 |
|
| 2021 |
Chen K, Ozturk K, Liefeld T, Reich M, Mesirov JP, Carter H, Fraley SI. A phenotypically supervised single-cell analysis protocol to study within-cell-type heterogeneity of cultured mammalian cells. Star Protocols. 2: 100561. PMID 34095869 DOI: 10.1016/j.xpro.2021.100561 |
0.01 |
|
| 2021 |
Sepich-Poore GD, Carter H, Knight R. Intratumoral bacteria generate a new class of therapeutically relevant tumor antigens in melanoma. Cancer Cell. 39: 601-603. PMID 33974857 DOI: 10.1016/j.ccell.2021.04.008 |
0.01 |
|
| 2021 |
William WN, Zhao X, Bianchi JJ, Lin HY, Cheng P, Lee JJ, Carter H, Alexandrov LB, Abraham JP, Spetzler DB, Dubinett SM, Cleveland DW, Cavenee W, Davoli T, Lippman SM. Immune evasion in HPV head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33952700 DOI: 10.1073/pnas.2022655118 |
0.01 |
|
| 2021 |
Klie A, Tsui BY, Mollah S, Skola D, Dow M, Hsu CN, Carter H. Increasing metadata coverage of SRA BioSample entries using deep learning-based named entity recognition. Database : the Journal of Biological Databases and Curation. 2021. PMID 33914028 DOI: 10.1093/database/baab021 |
0.01 |
|
| 2021 |
Zhou Y, Bastian IN, Long MD, Dow M, Li W, Liu T, Ngu RK, Antonucci L, Huang JY, Phung QT, Zhao XH, Banerjee S, Lin XJ, Wang H, Dang B, ... ... Carter H, et al. Activation of NF-κB and p300/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33602823 DOI: 10.1073/pnas.2025840118 |
0.01 |
|
| 2021 |
Castro A, Ozturk K, Zanetti M, Carter H. In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses. Plos One. 16: e0246731. PMID 33571241 DOI: 10.1371/journal.pone.0246731 |
0.01 |
|
| 2021 |
Zhang P, Kitchen-Smith I, Xiong L, Stracquadanio G, Brown K, Richter PH, Wallace MD, Bond E, Sahgal N, Moore S, Nornes S, De Val S, Surakhy M, Sims D, Wang X, ... ... Carter H, et al. Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression, and drug response. Cancer Research. PMID 33558336 DOI: 10.1158/0008-5472.CAN-20-0177 |
0.01 |
|
| 2021 |
Chen K, Ozturk K, Contreras RL, Simon J, McCann S, Chen WJ, Carter H, Fraley SI. Phenotypically supervised single-cell sequencing parses within-cell-type heterogeneity. Iscience. 24: 101991. PMID 33490901 DOI: 10.1016/j.isci.2020.101991 |
0.01 |
|
| 2021 |
Severance LM, Carter H, Contijoch FJ, McVeigh ER. Targeted Coronary Artery Calcium Screening in High-Risk Younger Individuals Using Consumer Genetic Screening Results. Jacc. Cardiovascular Imaging. PMID 33454274 DOI: 10.1016/j.jcmg.2020.11.013 |
0.01 |
|
| 2020 |
Castro A, Ozturk K, Zanetti M, Carter H. MHC-II constrains the natural neutralizing antibody response to the SARS-CoV-2 spike RBM in humans. Biorxiv : the Preprint Server For Biology. PMID 33398284 DOI: 10.1101/2020.12.26.424449 |
0.01 |
|
| 2020 |
Carter H. Loss of RNA-Binding Protein RBMS1 Promotes a Metastatic Transcriptional Program in Colorectal Cancer. Cancer Discovery. 10: 1261-1262. PMID 32873619 DOI: 10.1158/2159-8290.CD-20-0993 |
0.01 |
|
| 2020 |
Castro A, Pyke RM, Zhang X, Thompson WK, Day CP, Alexandrov LB, Zanetti M, Carter H. Strength of immune selection in tumors varies with sex and age. Nature Communications. 11: 4128. PMID 32807809 DOI: 10.1038/S41467-020-17981-0 |
0.01 |
|
| 2020 |
Dosset M, Castro A, Carter H, Zanetti M. Telomerase and CD4 T Cell Immunity in Cancer. Cancers. 12. PMID 32630460 DOI: 10.3390/Cancers12061687 |
0.01 |
|
| 2020 |
Steed TC, Treiber JM, Taha B, Engin HB, Carter H, Patel KS, Dale AM, Carter BS, Chen CC. Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state. Journal of Neuro-Oncology. PMID 32556864 DOI: 10.1007/s11060-020-03550-4 |
0.01 |
|
| 2020 |
Batista A, Rodvold JJ, Xian S, Searles SC, Lew A, Iwawaki T, Almanza G, Waller TC, Lin J, Jepsen K, Carter H, Zanetti M. IRE1α regulates macrophage polarization, PD-L1 expression, and tumor survival. Plos Biology. 18: e3000687. PMID 32520957 DOI: 10.1371/Journal.Pbio.3000687 |
0.01 |
|
| 2020 |
Rodvold JJ, Xian S, Nussbacher J, Tsui B, Cameron Waller T, Searles SC, Lew A, Jiang P, Babic I, Nomura N, Lin JH, Kesari S, Carter H, Zanetti M. IRE1α and IGF signaling predict resistance to an endoplasmic reticulum stress-inducing drug in glioblastoma cells. Scientific Reports. 10: 8348. PMID 32433555 DOI: 10.1038/S41598-020-65320-6 |
0.01 |
|
| 2020 |
Goodman AM, Castro A, Pyke RM, Okamura R, Kato S, Riviere P, Frampton G, Sokol E, Zhang X, Ball ED, Carter H, Kurzrock R. MHC-I genotype and tumor mutational burden predict response to immunotherapy. Genome Medicine. 12: 45. PMID 32430031 DOI: 10.1186/S13073-020-00743-4 |
0.01 |
|
| 2020 |
Surakhy M, Wallace M, Bond E, Grochola LF, Perez H, Di Giovannantonio M, Zhang P, Malkin D, Carter H, Parise IZS, Zambetti G, Komechen H, Paraizo MM, Pagadala MS, Pinto EM, et al. A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence. British Journal of Cancer. PMID 32147670 DOI: 10.1038/S41416-020-0764-3 |
0.01 |
|
| 2020 |
Stoner SA, Liu KTH, Andrews ET, Liu M, Arimoto KI, Yan M, Davis AG, Weng S, Dow M, Xian S, DeKelver RC, Carter H, Zhang DE. The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling. Blood Cancer Journal. 10: 16. PMID 32029705 DOI: 10.1038/s41408-020-0282-9 |
0.01 |
|
| 2020 |
Okonechnikov K, Hübner J, Chapman O, Chakraborty A, Pagadala M, Bump R, Chandran S, Kraft K, Hidalgo RA, Mundlos S, Wechsler-Reya R, Juarez EF, Coufal N, Levy M, Crawford J, ... ... Carter H, et al. EPEN-04. ONCOGENIC 3D TUMOR GENOME ORGANIZATION IDENTIFIES NEW THERAPEUTIC TARGETS IN EPENDYMOMA Neuro-Oncology. 22: iii308-iii308. DOI: 10.1093/neuonc/noaa222.145 |
0.01 |
|
| 2020 |
Castro A, Carter H. Mutagenic exposures shape immunotherapy responses Nature Cancer. 1: 1132-1133. DOI: 10.1038/s43018-020-00153-w |
0.01 |
|
| 2020 |
Severance L, Carter H, Contijoch F, McVeigh E. A Genetic Risk Score To Identify Young Individuals (aged 32-47) At Increased Risk Of Non-zero CAC Journal of Cardiovascular Computed Tomography. 14: S65. DOI: 10.1016/J.Jcct.2020.06.123 |
0.01 |
|
| 2019 |
Beri P, Popravko A, Yeoman B, Kumar A, Chen K, Hodzic E, Chiang A, Banisadr A, Placone JK, Carter H, Fraley SI, Katira P, Engler AJ. Cell adhesiveness serves as a biophysical marker for metastatic potential. Cancer Research. PMID 31857292 DOI: 10.1158/0008-5472.Can-19-1794 |
0.01 |
|
| 2019 |
Sriram K, Moyung K, Corriden R, Carter H, Insel PA. GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors. Plos Biology. 17: e3000434. PMID 31765370 DOI: 10.1371/Journal.Pbio.3000434 |
0.01 |
|
| 2019 |
Castro A, Ozturk K, Pyke RM, Xian S, Zanetti M, Carter H. Elevated neoantigen levels in tumors with somatic mutations in the HLA-A, HLA-B, HLA-C and B2M genes. Bmc Medical Genomics. 12: 107. PMID 31345234 DOI: 10.1186/S12920-019-0544-1 |
0.01 |
|
| 2019 |
Bromberg Y, Capriotti E, Carter H. VarI-COSI 2018: a forum for research advances in variant interpretation and diagnostics. Bmc Genomics. 20: 550. PMID 31307380 DOI: 10.1186/S12864-019-5862-3 |
0.01 |
|
| 2019 |
Monzon AM, Carraro M, Chiricosta L, Reggiani F, Han J, Ozturk K, Wang Y, Miller M, Bromberg Y, Capriotti E, Savojardo C, Babbi G, Martelli PL, Casadio R, Katsonis P, ... ... Carter H, et al. Performance of computational methods for the evaluation of Pericentriolar Material 1 missense variants in CAGI-5. Human Mutation. PMID 31260570 DOI: 10.1002/Humu.23856 |
0.01 |
|
| 2019 |
Carter H. Mutation hotspots may not be drug targets. Science (New York, N.Y.). 364: 1228-1229. PMID 31249043 DOI: 10.1126/science.aax9108 |
0.01 |
|
| 2019 |
Buckley AR, Ideker T, Carter H, Schork NJ. Rare variant phasing using paired tumor:normal sequence data. Bmc Bioinformatics. 20: 265. PMID 31132991 DOI: 10.1186/S12859-019-2753-1 |
0.01 |
|
| 2019 |
Severance LM, Contijoch FJ, Carter H, Fan CC, Seibert TM, Dale AM, McVeigh ER. Using a genetic risk score to calculate the optimal age for an individual to undergo coronary artery calcium screening. Journal of Cardiovascular Computed Tomography. PMID 31104941 DOI: 10.1016/J.Jcct.2019.05.005 |
0.01 |
|
| 2019 |
Liang H, Tsui BY, Ni H, Valentim CCS, Baxter SL, Liu G, Cai W, Kermany DS, Sun X, Chen J, He L, Zhu J, Tian P, Shao H, Zheng L, ... ... Carter H, et al. Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence. Nature Medicine. PMID 30742121 DOI: 10.1038/S41591-018-0335-9 |
0.01 |
|
| 2019 |
Davies T, Cowley A, Bennie J, Leyshon C, Inger R, Carter H, Robinson B, Duffy JP, Casalegno S, Lambert G, Gaston K. Correction: Popular interest in vertebrates does not reflect extinction risk and is associated with bias in conservation investment. Plos One. 14: e0212101. PMID 30726304 DOI: 10.1371/journal.pone.0212101 |
0.01 |
|
| 2019 |
Deshpande V, Luebeck J, Nguyen ND, Bakhtiari M, Turner KM, Schwab R, Carter H, Mischel PS, Bafna V. Exploring the landscape of focal amplifications in cancer using AmpliconArchitect. Nature Communications. 10: 392. PMID 30674876 DOI: 10.1038/S41467-018-08200-Y |
0.01 |
|
| 2019 |
Ozturk K, Carter H. Identifying Driver Interfaces Enriched for Somatic Missense Mutations in Tumors. Methods in Molecular Biology (Clifton, N.J.). 1907: 51-72. PMID 30542990 DOI: 10.1007/978-1-4939-8967-6_4 |
0.01 |
|
| 2019 |
Goodman A, Pyke R, Kato S, Okamura R, Sokol E, Frampton GM, Miller VA, Carter H, Kurzrock R. MHC-1 genotype as a predictor of response to immunotherapy. Journal of Clinical Oncology. 37: 149-149. DOI: 10.1200/Jco.2019.37.8_Suppl.149 |
0.01 |
|
| 2018 |
Marty Pyke R, Thompson WK, Salem RM, Font-Burgada J, Zanetti M, Carter H. Evolutionary Pressure against MHC Class II Binding Cancer Mutations. Cell. 175: 1991. PMID 30550793 DOI: 10.1016/j.cell.2018.11.050 |
0.01 |
|
| 2018 |
Capriotti E, Ozturk K, Carter H. Integrating molecular networks with genetic variant interpretation for precision medicine. Wiley Interdisciplinary Reviews. Systems Biology and Medicine. e1443. PMID 30548534 DOI: 10.1002/wsbm.1443 |
0.01 |
|
| 2018 |
Almanza G, Rodvold JJ, Tsui B, Jepsen K, Carter H, Zanetti M. Extracellular vesicles produced in B cells deliver tumor suppressor miR-335 to breast cancer cells disrupting oncogenic programming in vitro and in vivo. Scientific Reports. 8: 17581. PMID 30514916 DOI: 10.1038/S41598-018-35968-2 |
0.01 |
|
| 2018 |
Dow M, Pyke RM, Tsui BY, Alexandrov LB, Nakagawa H, Taniguchi K, Seki E, Harismendy O, Shalapour S, Karin M, Carter H, Font-Burgada J. Integrative genomic analysis of mouse and human hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 30287485 DOI: 10.1073/Pnas.1811029115 |
0.01 |
|
| 2018 |
Davies T, Cowley A, Bennie J, Leyshon C, Inger R, Carter H, Robinson B, Duffy J, Casalegno S, Lambert G, Gaston K. Popular interest in vertebrates does not reflect extinction risk and is associated with bias in conservation investment. Plos One. 13: e0203694. PMID 30256838 DOI: 10.1371/journal.pone.0203694 |
0.01 |
|
| 2018 |
Marty R, Thompson WK, Salem RM, Zanetti M, Carter H. Evolutionary Pressure against MHC Class II Binding Cancer Mutations. Cell. PMID 30245014 DOI: 10.1016/J.Cell.2018.08.048 |
0.01 |
|
| 2018 |
Buckley AR, Ideker T, Carter H, Harismendy O, Schork NJ. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas. Genome Medicine. 10: 69. PMID 30217226 DOI: 10.1186/S13073-018-0579-5 |
0.01 |
|
| 2018 |
Kiechle ES, McKenna CM, Carter H, Zeymo A, Gelfand BW, DeGeorge LM, Sauter DA, Mazer-Amirshahi M. Medication Allergy and Adverse Drug Reaction Documentation Discrepancies in an Urban, Academic Emergency Department. Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology. PMID 29968185 DOI: 10.1007/s13181-018-0671-7 |
0.01 |
|
| 2018 |
Ozturk K, Dow M, Carlin DE, Bejar R, Carter H. The emerging potential for network analysis to inform precision cancer medicine. Journal of Molecular Biology. PMID 29908887 DOI: 10.1016/J.Jmb.2018.06.016 |
0.01 |
|
| 2018 |
Zhang W, Bojorquez-Gomez A, Velez DO, Xu G, Sanchez KS, Shen JP, Chen K, Licon K, Melton C, Olson KM, Yu MK, Huang JK, Carter H, Farley EK, Snyder M, et al. A global transcriptional network connecting noncoding mutations to changes in tumor gene expression. Nature Genetics. PMID 29610481 DOI: 10.1038/S41588-018-0091-2 |
0.01 |
|
| 2018 |
Marty R, de Prisco N, Carter H, Font-Burgada J. MHC-I genotype drives early immune selection of oncogenic mutations. Molecular & Cellular Oncology. 5: e1409863. PMID 29487895 DOI: 10.1080/23723556.2017.1409863 |
0.01 |
|
| 2018 |
Marty R, Kaabinejadian S, Rossel D, Slifker MJ, Haar JVd, Engin HB, Prisco Nd, Ideker T, Hildebrand WH, Font-Burgada J, Carter H. Abstract IA24: Are tumors predictable? Inherited immune variation constrains tumor evolution Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Aacriaslc18-Ia24 |
0.01 |
|
| 2018 |
Marty R, Thompson W, Ideker T, Zanetti M, Carter H. Abstract 5727: MHC II complements MHC I in shaping the mutational landscape of tumors Cancer Research. 78: 5727-5727. DOI: 10.1158/1538-7445.Am2018-5727 |
0.01 |
|
| 2017 |
Glusman G, Rose PW, Prlić A, Dougherty J, Duarte JM, Hoffman AS, Barton GJ, Bendixen E, Bergquist T, Bock C, Brunk E, Buljan M, Burley SK, Cai B, Carter H, et al. Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework. Genome Medicine. 9: 113. PMID 29254494 DOI: 10.1186/S13073-017-0509-Y |
0.01 |
|
| 2017 |
Velez DO, Tsui B, Goshia T, Chute CL, Han A, Carter H, Fraley SI. 3D collagen architecture induces a conserved migratory and transcriptional response linked to vasculogenic mimicry. Nature Communications. 8: 1651. PMID 29162797 DOI: 10.1038/S41467-017-01556-7 |
0.01 |
|
| 2017 |
Marty R, Kaabinejadian S, Rossell D, Slifker MJ, van de Haar J, Engin HB, de Prisco N, Ideker T, Hildebrand WH, Font-Burgada J, Carter H. MHC-I Genotype Restricts the Oncogenic Mutational Landscape. Cell. PMID 29107334 DOI: 10.1016/j.cell.2017.09.050 |
0.01 |
|
| 2017 |
Xu RH, Wei W, Krawczyk M, Wang W, Luo H, Flagg K, Yi S, Shi W, Quan Q, Li K, Zheng L, Zhang H, Caughey BA, Zhao Q, Hou J, ... ... Carter H, et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nature Materials. PMID 29035356 DOI: 10.1038/Nmat4997 |
0.01 |
|
| 2017 |
Engin HB, Carlin D, Pratt D, Carter H. Modeling of RAS complexes supports roles in cancer for less studied partners. Bmc Biophysics. 10: 5. PMID 28815022 DOI: 10.1186/s13628-017-0037-6 |
0.01 |
|
| 2017 |
Carter H, Ideker T. Common genetic variation in the germline influences where and how tumors develop. Molecular & Cellular Oncology. 4: e1302905. PMID 28616579 DOI: 10.1080/23723556.2017.1302905 |
0.01 |
|
| 2017 |
Buckley AR, Standish KA, Bhutani K, Ideker T, Lasken RS, Carter H, Harismendy O, Schork NJ. Pan-cancer analysis reveals technical artifacts in TCGA germline variant calls. Bmc Genomics. 18: 458. PMID 28606096 DOI: 10.1186/S12864-017-3770-Y |
0.01 |
|
| 2017 |
Cai B, Li B, Kiga N, Thusberg J, Bergquist T, Chen YC, Niknafs N, Carter H, Tokheim C, Beleva-Guthrie V, Douville C, Bhattacharya R, Grace Yeo HT, Fan J, Sengupta S, et al. Matching phenotypes to whole genomes: Lessons learned from four iterations of the personal genome project community challenges. Human Mutation. PMID 28544481 DOI: 10.1002/Humu.23265 |
0.01 |
|
| 2017 |
Wang T, Tsui B, Kreisberg JF, Robertson NA, Gross AM, Yu MK, Carter H, Brown-Borg HM, Adams PD, Ideker T. Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment. Genome Biology. 18: 57. PMID 28351423 DOI: 10.1186/S13059-017-1186-2 |
0.01 |
|
| 2017 |
Carter H, Marty R, Hofree M, Gross A, Jensen J, Fisch KM, Wu X, DeBoever C, Van Nostrand EL, Song Y, Wheeler E, Kreisberg JF, Lippman SM, Yeo G, Gutkind S, et al. Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer. Cancer Discovery. PMID 28188128 DOI: 10.1158/2159-8290.Cd-16-1045 |
0.01 |
|
| 2017 |
Ortiz D, Tsui B, Goshia T, Ricker C, Carter H, Fraley SI. Abstract 1888: 3D matrix confinement triggers vascular mimicry through a conserved migratory and transcriptional response Cancer Research. 77: 1888-1888. DOI: 10.1158/1538-7445.Am2017-1888 |
0.01 |
|
| 2016 |
Coley RY, Fisher AJ, Mamawala M, Carter HB, Pienta KJ, Zeger SL. A Bayesian hierarchical model for prediction of latent health states from multiple data sources with application to active surveillance of prostate cancer. Biometrics. PMID 27548645 DOI: 10.1111/biom.12577 |
0.01 |
|
| 2016 |
Hornberger TA, Carter HN, Hood DA, Figueiredo VC, Dupont-Versteegden EE, Peterson CA, McCarthy JJ, Camera DM, Hawley JA, Chaillou T, Cheng AJ, Nader GA, Wüst RC, Houtkooper RH. Commentaries on Viewpoint: The rigorous study of exercise adaptations: Why mRNA might not be enough. Journal of Applied Physiology (Bethesda, Md. : 1985). 121: 597-600. PMID 27543661 DOI: 10.1152/japplphysiol.00509.2016 |
0.01 |
|
| 2016 |
Coley RY, Zeger SL, Mamawala M, Pienta KJ, Carter HB. Prediction of the Pathologic Gleason Score to Inform a Personalized Management Program for Prostate Cancer. European Urology. PMID 27523594 DOI: 10.1016/j.eururo.2016.08.005 |
0.01 |
|
| 2016 |
Hood DA, Tryon LD, Carter HN, Kim Y, Chen CC. Unravelling the mechanisms regulating muscle mitochondrial biogenesis. The Biochemical Journal. 473: 2295-314. PMID 27470593 DOI: 10.1042/BCJ20160009 |
0.01 |
|
| 2016 |
Carter HB. Optimizing Active Surveillance. European Urology. PMID 27460354 DOI: 10.1016/j.eururo.2016.07.017 |
0.01 |
|
| 2016 |
Levy E, Marty R, Gárate Calderón V, Woo B, Dow M, Armisen R, Carter H, Harismendy O. Immune DNA signature of T-cell infiltration in breast tumor exomes. Scientific Reports. 6: 30064. PMID 27452728 DOI: 10.1038/Srep30064 |
0.01 |
|
| 2016 |
Power S, Symons C, Carter H, Jones E, Amlôt R, Larner J, Matar H, Chilcott RP. Mass Casualty Decontamination in the United States: An Online Survey of Current Practice. Health Security. PMID 27442794 DOI: 10.1089/Hs.2016.0047 |
0.01 |
|
| 2016 |
Hofree M, Carter H, Kreisberg JF, Bandyopadhyay S, Mischel PS, Friend S, Ideker T. Challenges in identifying cancer genes by analysis of exome sequencing data. Nature Communications. 7: 12096. PMID 27417679 DOI: 10.1038/Ncomms12096 |
0.01 |
|
| 2016 |
Bromberg Y, Capriotti E, Carter H. VarI-SIG 2015: methods for personalized medicine - the role of variant interpretation in research and diagnostics. Bmc Genomics. 17: 425. PMID 27357578 DOI: 10.1186/S12864-016-2721-3 |
0.01 |
|
| 2016 |
Ma TM, Tosoian JJ, Schaeffer EM, Landis P, Wolf S, Macura KJ, Epstein JI, Mamawala M, Carter HB. The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance. European Urology. PMID 27236496 DOI: 10.1016/j.eururo.2016.05.021 |
0.01 |
|
| 2016 |
Emmett BA, Cooper D, Smart S, Jackson B, Thomas A, Cosby B, Evans C, Glanville H, McDonald JE, Malham SK, Marshall M, Jarvis S, Rajko-Nenow P, Webb GP, Ward S, ... ... Carter H, et al. Spatial patterns and environmental constraints on ecosystem services at a catchment scale. The Science of the Total Environment. PMID 27156120 DOI: 10.1016/J.Scitotenv.2016.04.004 |
0.01 |
|
| 2016 |
Carter HF, Lau C, Juma D, Wells B, Applegate RL. Intraoperative Red Blood Cell Transfusion in Infant Heart Transplant Patients Is Not Associated with Worsened Outcomes. Anesthesia and Analgesia. 122: 1567-77. PMID 27101500 DOI: 10.1213/ANE.0000000000001241 |
0.01 |
|
| 2016 |
Carter H, Price L. Managing and reviewing evidence-based changes. Nursing Times. 112: 14-7. PMID 27089753 |
0.01 |
|
| 2016 |
Trock BJ, Fedor H, Gurel B, Jenkins RB, Knudsen BS, Fine SW, Said JW, Carter HB, Lotan TL, De Marzo AM. PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27080984 DOI: 10.1038/Modpathol.2016.63 |
0.01 |
|
| 2016 |
Carter H, Price L. Assessing the need for service improvement. Nursing Times. 112: 15-7. PMID 27071238 |
0.01 |
|
| 2016 |
Engin HB, Kreisberg JF, Carter H. Structure-Based Analysis Reveals Cancer Missense Mutations Target Protein Interaction Interfaces. Plos One. 11: e0152929. PMID 27043210 DOI: 10.1371/Journal.Pone.0152929 |
0.01 |
|
| 2016 |
Patel HD, Chalfin HJ, Carter HB. Improving Prostate Cancer Screening and Diagnosis: Health Policy and Biomarkers Beyond PSA. Jama Oncology. PMID 27031887 DOI: 10.1001/jamaoncol.2016.0170 |
0.01 |
|
| 2016 |
Tosoian JJ, Carter HB, Lepor A, Loeb S. Active surveillance for prostate cancer: current evidence and contemporary state of practice. Nature Reviews. Urology. PMID 26954332 DOI: 10.1038/nrurol.2016.45 |
0.01 |
|
| 2016 |
Carter HB. Reply to M.C. Scholz et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26884568 DOI: 10.1200/JCO.2015.65.9755 |
0.01 |
|
| 2016 |
Whitman J, Dougherty PJ, Parkhurst GD, Olkowski J, Slade SG, Hovanesian J, Chu R, Dishler J, Tran DB, Lehmann R, Carter H, Steinert RF, Koch DD. Treatment of Presbyopia in Emmetropes Using a Shape-Changing Corneal Inlay: One-Year Clinical Outcomes. Ophthalmology. PMID 26804761 DOI: 10.1016/j.ophtha.2015.11.011 |
0.01 |
|
| 2016 |
Simpkin AJ, Donovan JL, Tilling K, Lane JA, Martin RM, Albertsen PC, Bill-Axelson A, Carter HB, Bosch R, Ferrucci L, Hamdy FC, Holmberg L, Metter EJ, Neal DE, Parker CC, et al. Prostate specific antigen patterns in US and European populations: comparison of six diverse cohorts. Bju International. PMID 26799945 DOI: 10.1111/bju.13422 |
0.01 |
|
| 2015 |
Johnson MH, Carter HB. Stromal Tumor of Uncertain Malignant Potential (STUMP) With PSA >500 ng/ml: A Case Report. Urology Case Reports. 3: 175-7. PMID 26793543 DOI: 10.1016/j.eucr.2015.06.012 |
0.01 |
|
| 2015 |
Reese AC, Carter HB. Reply. Urology. 86: 997. PMID 26590041 DOI: 10.1016/j.urology.2015.07.044 |
0.01 |
|
| 2015 |
Dianat SS, Carter HB, Macura KJ. Magnetic Resonance-Guided Prostate Biopsy. Magnetic Resonance Imaging Clinics of North America. 23: 621-31. PMID 26499279 DOI: 10.1016/j.mric.2015.05.005 |
0.01 |
|
| 2015 |
Hood DA, Tryon LD, Vainshtein A, Memme J, Chen C, Pauly M, Crilly MJ, Carter H. Exercise and the Regulation of Mitochondrial Turnover. Progress in Molecular Biology and Translational Science. 135: 99-127. PMID 26477912 DOI: 10.1016/bs.pmbts.2015.07.007 |
0.01 |
|
| 2015 |
Tosoian JJ, Sundi D, Trock BJ, Landis P, Epstein JI, Schaeffer EM, Carter HB, Mamawala M. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. European Urology. PMID 26456680 DOI: 10.1016/J.Eururo.2015.09.032 |
0.01 |
|
| 2015 |
Duchesne GM, Haworth A, Bone E, Carter H, Ebert MA, Gagliardi F, Gibbs A, Hornby C, Martin A, Sidhom M, Wood M, Jackson M. Testing the Assessment of New Radiation Oncology Technology and Treatments framework using the evaluation of post-prostatectomy radiotherapy techniques. Journal of Medical Imaging and Radiation Oncology. PMID 26439588 DOI: 10.1111/1754-9485.12390 |
0.01 |
|
| 2015 |
Atkinson CL, Lewis NC, Carter HH, Thijssen DH, Ainslie PN, Green DJ. Impact of sympathetic nervous system activity on post-exercise flow-mediated dilation in humans. The Journal of Physiology. PMID 26437709 DOI: 10.1113/JP270946 |
0.01 |
|
| 2015 |
Dianat SS, Carter HB, Schaeffer EM, Hamper UM, Epstein JI, Macura KJ. Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy. The Canadian Journal of Urology. 22: 7965-72. PMID 26432966 |
0.01 |
|
| 2015 |
Zhu G, Liu Z, Epstein JI, Davis C, Christudass CS, Carter HB, Landis P, Zhang H, Chung JY, Hewitt SM, Miller MC, Veltri RW. A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26404961 DOI: 10.1158/1055-9965.EPI-15-0496 |
0.01 |
|
| 2015 |
Reese AC, Feng Z, Landis P, Trock BJ, Epstein JI, Carter HB. Predictors of Adverse Pathology in Men Undergoing Radical Prostatectomy Following Initial Active Surveillance. Urology. PMID 26335496 DOI: 10.1016/J.Urology.2015.07.039 |
0.01 |
|
| 2015 |
Tosoian JJ, Mamawala M, Epstein JI, Landis P, Wolf S, Trock BJ, Carter HB. Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 3379-85. PMID 26324359 DOI: 10.1200/Jco.2015.62.5764 |
0.01 |
|
| 2015 |
Atkinson CL, Carter HH, Naylor LH, Dawson EA, Marusic P, Hering D, Schlaich MP, Thijssen DH, Green DJ. Opposing effects of shear-mediated dilation and myogenic constriction on artery diameter in response to handgrip exercise in humans. Journal of Applied Physiology (Bethesda, Md. : 1985). 119: 858-64. PMID 26294751 DOI: 10.1152/japplphysiol.01086.2014 |
0.01 |
|
| 2015 |
Font-Burgada J, Shalapour S, Ramaswamy S, Hsueh B, Rossell D, Umemura A, Taniguchi K, Nakagawa H, Valasek MA, Ye L, Kopp JL, Sander M, Carter H, Deisseroth K, Verma IM, et al. Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer. Cell. 162: 766-79. PMID 26276631 DOI: 10.1016/J.Cell.2015.07.026 |
0.01 |
|
| 2015 |
Rowe SP, Gage KL, Faraj SF, Macura KJ, Cornish TC, Gonzalez-Roibon N, Guner G, Munari E, Partin AW, Pavlovich CP, Han M, Carter HB, Bivalacqua TJ, Blackford A, Holt D, et al. 18F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1003-10. PMID 26069305 DOI: 10.2967/Jnumed.115.154336 |
0.01 |
|
| 2015 |
Carter HN, Chen CC, Hood DA. Mitochondria, muscle health, and exercise with advancing age. Physiology (Bethesda, Md.). 30: 208-23. PMID 25933821 DOI: 10.1152/physiol.00039.2014 |
0.01 |
|
| 2015 |
Reis Lde O, Carter HB. The Mind: Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind? International Braz J Urol : Official Journal of the Brazilian Society of Urology. 41: 10-4. PMID 25928505 DOI: 10.1590/S1677-5538.IBJU.2015.01.03 |
0.01 |
|
| 2015 |
Carter H, Drury J, Rubin GJ, Williams R, Amlôt R. Applying crowd psychology to develop recommendations for the management of mass decontamination. Health Security. 13: 45-53. PMID 25812428 DOI: 10.1089/Hs.2014.0061 |
0.01 |
|
| 2015 |
Atkinson CL, Carter HH, Dawson EA, Naylor LH, Thijssen DH, Green DJ. Impact of handgrip exercise intensity on brachial artery flow-mediated dilation. European Journal of Applied Physiology. 115: 1705-13. PMID 25805181 DOI: 10.1007/s00421-015-3157-1 |
0.01 |
|
| 2015 |
Ko JS, Chalfin H, Trock BJ, Feng Z, Humphreys E, Park SW, Carter HB, Frick KD, Han M. Variability in Medicare utilization and payment among urologists. Urology. 85: 1045-50. PMID 25746578 DOI: 10.1016/J.Urology.2014.11.054 |
0.01 |
|
| 2015 |
Carter HB. Active surveillance for favorable risk prostate cancer. Current Opinion in Urology. 25: 230-1. PMID 25730328 DOI: 10.1097/MOU.0000000000000167 |
0.01 |
|
| 2015 |
Matoso A, Hassan O, Petrozzino F, Rao BV, Carter HB, Epstein JI. Radical Prostatectomy Findings in Men on Active Surveillance: Variable Findings Dependent on Reason for Surgery and Entry Criteria. The Journal of Urology. PMID 25725419 DOI: 10.1016/j.juro.2015.02.085 |
0.01 |
|
| 2015 |
Carter HB. Aligning evidence and practice: future research needs to increase utilization of active surveillance for favorable risk prostate cancer. Current Opinion in Urology. 25: 277-82. PMID 25692722 DOI: 10.1097/MOU.0000000000000153 |
0.01 |
|
| 2015 |
Pepose JS, Hayashida J, Hovanesian J, Davies J, Labor PK, Whitman J, Carter H, Colvard M, Buckhurst PJ, Khodai O, Mittleman D, Feinerman G. Safety and effectiveness of a new toric presbyopia-correcting posterior chamber silicone intraocular lens. Journal of Cataract and Refractive Surgery. 41: 295-305. PMID 25661122 DOI: 10.1016/j.jcrs.2014.05.043 |
0.01 |
|
| 2015 |
Engin HB, Hofree M, Carter H. Identifying mutation specific cancer pathways using a structurally resolved protein interaction network. Pacific Symposium On Biocomputing. Pacific Symposium On Biocomputing. 84-95. PMID 25592571 |
0.01 |
|
| 2015 |
Alam R, Carter HB, Landis P, Epstein JI, Mamawala M. Conditional probability of reclassification in an active surveillance program for prostate cancer. The Journal of Urology. 193: 1950-5. PMID 25572035 DOI: 10.1016/j.juro.2014.12.091 |
0.01 |
|
| 2015 |
Kaye DR, Mullins JK, Carter HB, Bivalacqua TJ. Robotic surgery in urological oncology: patient care or market share? Nature Reviews. Urology. 12: 55-60. PMID 25535000 DOI: 10.1038/Nrurol.2014.339 |
0.01 |
|
| 2015 |
Macura KJ, Carter HB. Reply: To PMID 25440986. Urology. 85: 154. PMID 25530378 DOI: 10.1016/j.urology.2014.06.089 |
0.01 |
|
| 2015 |
Carter HB, Albertsen PC. Re: Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening. The Journal of Urology. 193: 1063-4; discussion 1. PMID 25476113 DOI: 10.1016/j.juro.2014.09.114 |
0.01 |
|
| 2015 |
Dianat SS, Carter HB, Pienta KJ, Schaeffer EM, Landis PK, Epstein JI, Trock BJ, Macura KJ. Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomes. Urology. 85: 147-53. PMID 25440986 DOI: 10.1016/J.Urology.2014.06.085 |
0.01 |
|
| 2015 |
Sundi D, Faisal FA, Trock BJ, Landis PK, Feng Z, Ross AE, Carter HB, Schaeffer EM. Reclassification rates are higher among African American men than Caucasians on active surveillance. Urology. 85: 155-60. PMID 25440814 DOI: 10.1016/J.Urology.2014.08.014 |
0.01 |
|
| 2015 |
Duchesne GM, Grand M, Kron T, Haworth A, Corry J, Jackson M, Ng M, Besuijen D, Carter HE, Martin A, Schofield D, Gebski V, Torony J, Kovacev O, Amin R, et al. Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework. Journal of Medical Imaging and Radiation Oncology. 59: 363-70. PMID 25345713 DOI: 10.1111/1754-9485.12255 |
0.01 |
|
| 2015 |
Loeb S, Peskoe SB, Joshu CE, Huang WY, Hayes RB, Carter HB, Isaacs WB, Platz EA. Do environmental factors modify the genetic risk of prostate cancer? Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 213-20. PMID 25342390 DOI: 10.1158/1055-9965.Epi-14-0786-T |
0.01 |
|
| 2015 |
Patel HD, Humphreys E, Trock BJ, Han M, Carter HB. Practice patterns and individual variability of surgeons performing radical prostatectomy at a high volume academic center. The Journal of Urology. 193: 812-9. PMID 25196659 DOI: 10.1016/J.Juro.2014.08.101 |
0.01 |
|
| 2015 |
Cohen JE, Landis P, Trock BJ, Patel HD, Ball MW, Auwaerter PG, Schaeffer E, Carter HB. Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis. The Journal of Urology. 193: 552-6. PMID 25111911 DOI: 10.1016/J.Juro.2014.08.008 |
0.01 |
|
| 2015 |
Pugh CJ, Sprung VS, Ono K, Spence AL, Thijssen DH, Carter HH, Green DJ. The effect of water immersion during exercise on cerebral blood flow. Medicine and Science in Sports and Exercise. 47: 299-306. PMID 24977699 DOI: 10.1249/MSS.0000000000000422 |
0.01 |
|
| 2015 |
Kates M, Tosoian JJ, Trock BJ, Feng Z, Carter HB, Partin AW. Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols. Bju International. 115: 216-22. PMID 24904995 DOI: 10.1111/Bju.12828 |
0.01 |
|
| 2015 |
Haffner MC, De Marzo AM, Yegnasubramanian S, Epstein JI, Carter HB. Diagnostic challenges of clonal heterogeneity in prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: e38-40. PMID 24638011 DOI: 10.1200/Jco.2013.50.3540 |
0.01 |
|
| 2015 |
Pillai M, Welsh V, Sedgeman K, Gazet AC, Staddon J, Carter H. Introduction of a manual vacuum aspiration service: a model of service within a NHS Sexual Health Service. The Journal of Family Planning and Reproductive Health Care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists. 41: 27-32. PMID 24563218 DOI: 10.1136/jfprhc-2013-100700 |
0.01 |
|
| 2015 |
Carter H, Thompson J. Defining the paramedic process. Australian Journal of Primary Health. 21: 22-6. PMID 24176226 DOI: 10.1071/PY13059 |
0.01 |
|
| 2015 |
Font-Burgada J, Shalapour S, Ramaswamy S, Hsueh B, Rossell D, Umemura A, Taniguchi K, Nakagawa H, Valasek MA, Ye L, Kopp JL, Sander M, Carter H, Deisseroth K, Verma IM, et al. Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer Cell. 162: 766-779. DOI: 10.1016/j.cell.2015.07.026 |
0.01 |
|
| 2014 |
Loeb S, Carter HB, Schwartz M, Fagerlin A, Braithwaite RS, Lepor H. Heterogeneity in active surveillance protocols worldwide. Reviews in Urology. 16: 202-3. PMID 25548550 |
0.01 |
|
| 2014 |
Carter HH, Spence AL, Atkinson CL, Pugh CJ, Cable NT, Thijssen DH, Naylor LH, Green DJ. Distinct effects of blood flow and temperature on cutaneous microvascular adaptation. Medicine and Science in Sports and Exercise. 46: 2113-21. PMID 25338190 DOI: 10.1249/MSS.0000000000000349 |
0.01 |
|
| 2014 |
Carter H, Brown M. Considerations when supporting or opposing a national licensing exam. Bmj (Clinical Research Ed.). 349: g6300. PMID 25336359 DOI: 10.1136/Bmj.G6300 |
0.01 |
|
| 2014 |
Xia J, Trock BJ, Gulati R, Mallinger L, Cooperberg MR, Carroll PR, Carter HB, Etzioni R. Overdetection of recurrence after radical prostatectomy: estimates based on patient and tumor characteristics. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5302-10. PMID 25320374 DOI: 10.1158/1078-0432.Ccr-13-3366 |
0.01 |
|
| 2014 |
Chen YC, Douville C, Wang C, Niknafs N, Yeo G, Beleva-Guthrie V, Carter H, Stenson PD, Cooper DN, Li B, Mooney S, Karchin R. A probabilistic model to predict clinical phenotypic traits from genome sequencing. Plos Computational Biology. 10: e1003825. PMID 25188385 DOI: 10.1371/Journal.Pcbi.1003825 |
0.01 |
|
| 2014 |
Amin MB, Lin DW, Gore JL, Srigley JR, Samaratunga H, Egevad L, Rubin M, Nacey J, Carter HB, Klotz L, Sandler H, Zietman AL, Holden S, Montironi R, Humphrey PA, et al. The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation. Archives of Pathology & Laboratory Medicine. 138: 1387-405. PMID 25092589 DOI: 10.5858/arpa.2014-0219-SA |
0.01 |
|
| 2014 |
Gross AM, Orosco RK, Shen JP, Egloff AM, Carter H, Hofree M, Choueiri M, Coffey CS, Lippman SM, Hayes DN, Cohen EE, Grandis JR, Nguyen QT, Ideker T. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. Nature Genetics. 46: 939-43. PMID 25086664 DOI: 10.1038/Ng.3051 |
0.01 |
|
| 2014 |
Carter HB. Reducing prostate cancer deaths: unsupported speculation about the androgen deprivation hypothesis. European Urology. 66: 973-4. PMID 25018035 DOI: 10.1016/j.eururo.2014.06.051 |
0.01 |
|
| 2014 |
Carter HE, Martin A, Schofield D, Duchesne G, Haworth A, Hornby C, Sidhom M, Jackson M. A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 112: 187-93. PMID 24929702 DOI: 10.1016/j.radonc.2014.03.020 |
0.01 |
|
| 2014 |
Berger ZD, Yeh JC, Carter HB, Pollack CE. Characteristics and experiences of patients with localized prostate cancer who left an active surveillance program. The Patient. 7: 427-36. PMID 24920082 DOI: 10.1007/s40271-014-0066-z |
0.01 |
|
| 2014 |
Tseng KS, Kulkarni S, Humphreys EB, Carter HB, Mostwin JL, Partin AW, Han M, Wu CL. Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational study. Regional Anesthesia and Pain Medicine. 39: 284-8. PMID 24918335 DOI: 10.1097/AAP.0000000000000108 |
0.01 |
|
| 2014 |
Mullins JK, Carter HB. Multiparametric magnetic resonance imaging (MRI) and active surveillance for prostate cancer: future directions. Bju International. 113: 844-5. PMID 24905655 DOI: 10.1111/bju.12473 |
0.01 |
|
| 2014 |
Faisal FA, Sundi D, Pierorazio PM, Ball MW, Humphreys EB, Han M, Epstein JI, Partin AW, Carter HB, Bivalacqua TJ, Schaeffer EM, Ross AE. Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature. Bju International. 114: E120-9. PMID 24731026 DOI: 10.1111/Bju.12771 |
0.01 |
|
| 2014 |
Carter HB. Baseline PSA testing for men in their 40s: testing in average-risk men aged 40 to 50 years should not be routinely performed. Oncology (Williston Park, N.Y.). 28: 155-6. PMID 24701706 |
0.01 |
|
| 2014 |
Kryvenko ON, Carter HB, Trock BJ, Epstein JI. Biopsy criteria for determining appropriateness for active surveillance in the modern era. Urology. 83: 869-74. PMID 24680457 DOI: 10.1016/J.Urology.2013.12.054 |
0.01 |
|
| 2014 |
Jarow JP, Thompson IM, Kluetz PG, Baxley J, Sridhara R, Scardino P, Carroll P, Albertsen P, Carter HB, Brawley O, Sartor O, Sandler H, Kiefert JJ, Morton RA. Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop. Urology. 83: 975-8. PMID 24661332 DOI: 10.1016/j.urology.2013.10.087 |
0.01 |
|
| 2014 |
Carter H, Drury J, Amlôt R, Rubin GJ, Williams R. Effective responder communication improves efficiency and psychological outcomes in a mass decontamination field experiment: implications for public behaviour in the event of a chemical incident. Plos One. 9: e89846. PMID 24595097 DOI: 10.1371/Journal.Pone.0089846 |
0.01 |
|
| 2014 |
Carter HH, Spence AL, Pugh CJ, Ainslie P, Naylor LH, Green DJ. Cardiovascular responses to water immersion in humans: impact on cerebral perfusion. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 306: R636-40. PMID 24553298 DOI: 10.1152/ajpregu.00516.2013 |
0.01 |
|
| 2014 |
Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R. Overdiagnosis and overtreatment of prostate cancer. European Urology. 65: 1046-55. PMID 24439788 DOI: 10.1016/J.Eururo.2013.12.062 |
0.01 |
|
| 2014 |
Carter HH, Spence AL, Atkinson CL, Pugh CJ, Naylor LH, Green DJ. Repeated core temperature elevation induces conduit artery adaptation in humans. European Journal of Applied Physiology. 114: 859-65. PMID 24399113 DOI: 10.1007/s00421-013-2817-2 |
0.01 |
|
| 2014 |
Wang CC, Carter HB, Epstein JI. Value of transition zone biopsy in active surveillance of prostate cancer. The Journal of Urology. 191: 1755-9. PMID 24316092 DOI: 10.1016/j.juro.2013.11.058 |
0.01 |
|
| 2014 |
Fuller NR, Carter H, Schofield D, Hauner H, Jebb SA, Colagiuri S, Caterson ID. Cost effectiveness of primary care referral to a commercial provider for weight loss treatment, relative to standard care: a modelled lifetime analysis. International Journal of Obesity (2005). 38: 1104-9. PMID 24301133 DOI: 10.1038/ijo.2013.227 |
0.01 |
|
| 2014 |
Carter HE, Fraaije BA, West JS, Kelly SL, Mehl A, Shaw MW, Cools HJ. Alterations in the predicted regulatory and coding regions of the sterol 14α-demethylase gene (CYP51) confer decreased azole sensitivity in the oilseed rape pathogen Pyrenopeziza brassicae. Molecular Plant Pathology. 15: 513-22. PMID 24298976 DOI: 10.1111/Mpp.12106 |
0.01 |
|
| 2014 |
Saleem A, Carter HN, Hood DA. p53 is necessary for the adaptive changes in cellular milieu subsequent to an acute bout of endurance exercise. American Journal of Physiology. Cell Physiology. 306: C241-9. PMID 24284795 DOI: 10.1152/ajpcell.00270.2013 |
0.01 |
|
| 2014 |
Carter H, Karchin R. Predicting the functional consequences of somatic missense mutations found in tumors. Methods in Molecular Biology (Clifton, N.J.). 1101: 135-59. PMID 24233781 DOI: 10.1007/978-1-62703-721-1_8 |
0.01 |
|
| 2014 |
Carter HE, Zannino D, John Simes R, Schofield DJ, Howard K, Zalcberg JR, Price TJ, Tebbutt NC. The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX study. European Journal of Cancer (Oxford, England : 1990). 50: 535-43. PMID 24215848 DOI: 10.1016/j.ejca.2013.09.028 |
0.01 |
|
| 2014 |
Dekerle J, Barstow TJ, Regan L, Carter H. The critical power concept in all-out isokinetic exercise. Journal of Science and Medicine in Sport / Sports Medicine Australia. 17: 640-4. PMID 24183173 DOI: 10.1016/J.Jsams.2013.09.003 |
0.01 |
|
| 2014 |
Inoue LY, Trock BJ, Partin AW, Carter HB, Etzioni R. Modeling grade progression in an active surveillance study. Statistics in Medicine. 33: 930-9. PMID 24123208 DOI: 10.1002/Sim.6003 |
0.01 |
|
| 2014 |
Patel HD, Feng Z, Landis P, Trock BJ, Epstein JI, Carter HB. Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer. The Journal of Urology. 191: 629-37. PMID 24060641 DOI: 10.1016/J.Juro.2013.09.029 |
0.01 |
|
| 2014 |
Gross AM, Orosco RK, Shen JP, Egloff AM, Carter H, Hoffree M, Choueiri M, Coffey CS, Lippman SM, Hayes DN, Cohen EE, Grandis JR, Nguyen QT, Ideker T. Abstract 3821: A prognostic model of head and neck cancer ties TP53 mutation to 3p loss Cancer Research. 74: 3821-3821. DOI: 10.1158/1538-7445.Am2014-3821 |
0.01 |
|
| 2013 |
Hill SY, Lichenstein S, Wang S, Carter H, McDermott M. Caudate Volume in Offspring at Ultra High Risk for Alcohol Dependence: COMT Val158Met, DRD2, Externalizing Disorders, and Working Memory. Advances in Molecular Imaging. 3: 43-54. PMID 25364629 DOI: 10.4236/ami.2013.34007 |
0.01 |
|
| 2013 |
Hill SY, Wang S, Carter H, McDermott MD, Zezza N, Stiffler S. Amygdala Volume in Offspring from Multiplex for Alcohol Dependence Families: The Moderating Influence of Childhood Environment and 5-HTTLPR Variation. Journal of Alcoholism and Drug Dependence. PMID 25285331 DOI: 10.4172/2329-6488.S1-001 |
0.01 |
|
| 2013 |
Bonekamp D, Bonekamp S, Mullins JK, Epstein JI, Carter HB, Macura KJ. Multiparametric magnetic resonance imaging characterization of prostate lesions in the active surveillance population: incremental value of magnetic resonance imaging for prediction of disease reclassification. Journal of Computer Assisted Tomography. 37: 948-56. PMID 24270118 DOI: 10.1097/RCT.0b013e31829ae20a |
0.01 |
|
| 2013 |
Carter H, Goodwin S. Understanding clinical review following a death in custody. Nursing Standard (Royal College of Nursing (Great Britain) : 1987). 28: 54-9. PMID 24251516 DOI: 10.7748/ns2013.11.28.12.54.e7993 |
0.01 |
|
| 2013 |
Carter H, Hofree M, Ideker T. Genotype to phenotype via network analysis. Current Opinion in Genetics & Development. 23: 611-21. PMID 24238873 DOI: 10.1016/J.Gde.2013.10.003 |
0.01 |
|
| 2013 |
Hofree M, Shen JP, Carter H, Gross A, Ideker T. Network-based stratification of tumor mutations. Nature Methods. 10: 1108-15. PMID 24037242 DOI: 10.1038/Nmeth.2651 |
0.01 |
|
| 2013 |
Dixon B, Smith R, Campbell DJ, Tobin A, Newcomb AE, Rosalion A, Opeskin K, Carter H, Scott DA, Santamaria JD. The effect of etanercept on lung leukocyte margination and fibrin deposition after cardiac surgery. American Journal of Respiratory and Critical Care Medicine. 188: 751-4. PMID 24032386 DOI: 10.1164/rccm.201301-0120LE |
0.01 |
|
| 2013 |
Bivalacqua TJ, Pierorazio PM, Gorin MA, Allaf ME, Carter HB, Walsh PC. Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy. Urology. 82: 653-8. PMID 23987158 DOI: 10.1016/J.Urology.2013.03.086 |
0.01 |
|
| 2013 |
Carter HD, Bowsher G. Hunt's priorities on entitlement to use the NHS are wrong. Bmj (Clinical Research Ed.). 347: f5105. PMID 23963551 DOI: 10.1136/bmj.f5105 |
0.01 |
|
| 2013 |
Carter HB. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale. Bju International. 112: 543-7. PMID 23924423 DOI: 10.1111/bju.12318 |
0.01 |
|
| 2013 |
Gartner JJ, Parker SC, Prickett TD, Dutton-Regester K, Stitzel ML, Lin JC, Davis S, Simhadri VL, Jha S, Katagiri N, Gotea V, Teer JK, Wei X, Morken MA, Bhanot UK, ... ... Carter H, et al. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proceedings of the National Academy of Sciences of the United States of America. 110: 13481-6. PMID 23901115 DOI: 10.1073/Pnas.1304227110 |
0.01 |
|
| 2013 |
Gonzalez-Perez A, Mustonen V, Reva B, Ritchie GR, Creixell P, Karchin R, Vazquez M, Fink JL, Kassahn KS, Pearson JV, Bader GD, Boutros PC, Muthuswamy L, Ouellette BF, Reimand J, ... ... Carter H, et al. Computational approaches to identify functional genetic variants in cancer genomes. Nature Methods. 10: 723-9. PMID 23900255 DOI: 10.1038/Nmeth.2562 |
0.01 |
|
| 2013 |
Carter H, Douville C, Stenson PD, Cooper DN, Karchin R. Identifying Mendelian disease genes with the variant effect scoring tool. Bmc Genomics. 14: S3. PMID 23819870 DOI: 10.1186/1471-2164-14-S3-S3 |
0.01 |
|
| 2013 |
Chen YC, Carter H, Parla J, Kramer M, Goes FS, Pirooznia M, Zandi PP, McCombie WR, Potash JB, Karchin R. A hybrid likelihood model for sequence-based disease association studies. Plos Genetics. 9: e1003224. PMID 23358228 DOI: 10.1371/Journal.Pgen.1003224 |
0.01 |
|
| 2013 |
Douville C, Carter H, Kim R, Niknafs N, Diekhans M, Stenson PD, Cooper DN, Ryan M, Karchin R. CRAVAT: cancer-related analysis of variants toolkit. Bioinformatics (Oxford, England). 29: 647-8. PMID 23325621 DOI: 10.1093/Bioinformatics/Btt017 |
0.01 |
|
| 2013 |
Hofree M, Shen JP, Carter H, Gross A, Ideker T. Abstract A14: Network-based stratification: Combining genome-scale somatic mutation profiles with genetic interaction networks to identify clinically relevant subtypes in high grade serous ovarian carcinoma Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A14 |
0.01 |
|
| 2012 |
Liang H, Cheung LW, Li J, Ju Z, Yu S, Stemke-Hale K, Dogruluk T, Lu Y, Liu X, Gu C, Guo W, Scherer SE, Carter H, Westin SN, Dyer MD, et al. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Research. 22: 2120-9. PMID 23028188 DOI: 10.1101/Gr.137596.112 |
0.01 |
|
| 2012 |
Jiao X, Wood LD, Lindman M, Jones S, Buckhaults P, Polyak K, Sukumar S, Carter H, Kim D, Karchin R, Sjöblom T. Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers. Genes, Chromosomes & Cancer. 51: 480-9. PMID 22302350 DOI: 10.1002/Gcc.21935 |
0.01 |
|
| 2011 |
Wu J, Jiao Y, Dal Molin M, Maitra A, de Wilde RF, Wood LD, Eshleman JR, Goggins MG, Wolfgang CL, Canto MI, Schulick RD, Edil BH, Choti MA, Adsay V, Klimstra DS, ... ... Carter H, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proceedings of the National Academy of Sciences of the United States of America. 108: 21188-93. PMID 22158988 DOI: 10.1073/Pnas.1118046108 |
0.01 |
|
| 2011 |
Zhang X, Reis M, Khoriaty R, Li Y, Ouillette P, Samayoa J, Carter H, Karchin R, Li M, Diaz LA, Velculescu VE, Papadopoulos N, Kinzler KW, Vogelstein B, Malek SN. Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia. Leukemia. 25: 1908-10. PMID 21701494 DOI: 10.1038/Leu.2011.163 |
0.01 |
|
| 2011 |
Wong WC, Kim D, Carter H, Diekhans M, Ryan MC, Karchin R. CHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancer. Bioinformatics (Oxford, England). 27: 2147-8. PMID 21685053 DOI: 10.1093/Bioinformatics/Btr357 |
0.01 |
|
| 2011 |
Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y, Hartigan J, et al. The genetic landscape of the childhood cancer medulloblastoma. Science (New York, N.Y.). 331: 435-9. PMID 21163964 DOI: 10.1126/Science.1198056 |
0.01 |
|
| 2010 |
Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, Karchin R, Kinzler KW, Vogelstein B, Nowak MA. Accumulation of driver and passenger mutations during tumor progression Proceedings of the National Academy of Sciences of the United States of America. 107: 18545-18550. PMID 20876136 DOI: 10.1073/Pnas.1010978107 |
0.01 |
|
| 2010 |
Carter H, Samayoa J, Hruban RH, Karchin R. Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM). Cancer Biology & Therapy. 10: 582-7. PMID 20581473 DOI: 10.4161/Cbt.10.6.12537 |
0.01 |
|
| 2009 |
Carter H, Chen S, Isik L, Tyekucheva S, Velculescu VE, Kinzler KW, Vogelstein B, Karchin R. Cancer-specific high-throughput annotation of somatic mutations: Computational prediction of driver missense mutations Cancer Research. 69: 6660-6667. PMID 19654296 DOI: 10.1158/0008-5472.Can-09-1133 |
0.01 |
|
| 2009 |
Pieper U, Eswar N, Webb BM, Eramian D, Kelly L, Barkan DT, Carter H, Mankoo P, Karchin R, Marti-Renom MA, Davis FP, Sali A. MODBASE, a database of annotated comparative protein structure models and associated resources. Nucleic Acids Research. 37: D347-54. PMID 18948282 DOI: 10.1093/nar/gkn791 |
0.01 |
|
| 2008 |
Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (New York, N.Y.). 321: 1801-6. PMID 18772397 DOI: 10.1126/Science.1164368 |
0.01 |
|
| 2008 |
Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, et al. An integrated genomic analysis of human glioblastoma multiforme. Science (New York, N.Y.). 321: 1807-12. PMID 18772396 DOI: 10.1126/Science.1164382 |
0.01 |
|
| Hide low-probability matches. |